Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of January 4, 2025 • 3:00 AM ET

Date/Time Source News Release
12/19/2024 07:00 AM EST GlobeNewswire Skye Bioscience to Present at J.P. Morgan Healthcare Conference
11/18/2024 07:00 AM EST GlobeNewswire Skye Bioscience to Participate in Upcoming December Healthcare Investment Conferences
11/14/2024 07:00 AM EST GlobeNewswire Skye Bioscience Surpasses 50% Patient Enrollment in Phase 2 Obesity Study of Differentiated CB1 Inhibitor
11/07/2024 04:01 PM EST GlobeNewswire Skye Bioscience Reports Third Quarter 2024 Financial Results and Recent Highlights
11/04/2024 07:00 AM EST GlobeNewswire Skye Bioscience Demonstrates Prominent Role of Peripheral CB1 Inhibition and Achieves Significant Weight Loss with Novel CB1-inhibiting Antibody, Nimacimab, in Preclinical Model
11/01/2024 07:00 AM EDT GlobeNewswire Skye Bioscience to Announce Third Quarter 2024 Results
10/29/2024 07:00 AM EDT GlobeNewswire Skye Bioscience Names Independent Director Paul Grayson as Chairman of the Board
10/21/2024 07:00 AM EDT GlobeNewswire Skye Bioscience to Participate in Upcoming November Healthcare Investment Conferences
09/23/2024 07:00 AM EDT GlobeNewswire Skye Bioscience Comments on Monlunabant Phase 2 Top-line Data and Reiterates Confidence in Nimacimab Clinical Development Plan
09/03/2024 07:00 AM EDT GlobeNewswire Skye Bioscience Appoints Puneet S. Arora, MD, as Chief Medical Officer
Page

Additional News

As of January 4, 2025 • 3:00 AM ET

Date/Time Source News Release
12/10/2024 08:32 AM EST SeekingAlpha Skye Bioscience: Nimacimab Targets Safer Weight Loss, Speculative Buy
11/27/2024 04:31 AM EST US Earnings Reports Expected earnings - Skye Bioscience Inc.
11/08/2024 05:14 PM EST Stock Traders Daily (SKYE) Technical Pivots with Risk Controls
11/07/2024 10:36 PM EST SeekingAlpha Skye Bioscience, Inc. (SKYE) Q3 2024 Earnings Call Transcript
11/07/2024 05:05 PM EST SeekingAlpha Skye Bioscience GAAP EPS of -$0.10 beats by $0.15
09/23/2024 12:27 PM EDT SeekingAlpha Skye stock rallies 22% following weight-loss drug update
09/20/2024 04:30 PM EDT QM US Market Movers News US Companies Moving the Markets, Evening edition
Fri, Sep 20, 2024 as of 4:00 pm ET
09/20/2024 10:00 AM EDT QM US Market Movers News US Companies Moving the Markets, Morning edition
Fri, Sep 20, 2024 as of 10.00 am ET
09/04/2024 11:26 AM EDT SeekingAlpha Skye: Moving Weight Loss Drugs To The Next Level
09/03/2024 07:49 AM EDT SeekingAlpha Skye Bioscience appoints Puneet Arora as chief medical officer
Page